Skip to main content
Top
Published in: Health and Quality of Life Outcomes 1/2012

Open Access 01-12-2012 | Research

Health-related quality of life in patients with dual diagnosis: clinical correlates

Authors: Irina Benaiges, Gemma Prat, Ana Adan

Published in: Health and Quality of Life Outcomes | Issue 1/2012

Login to get access

Abstract

Background

Although the studies published so far have found an affectation in the Health Related Quality of Life (HRQOL) in both psychiatric and substance use dependence disorders, very few studies have applied HRQOL as an assessment measure in patients suffering both comorbid conditions, or Dual Diagnosis. The aim of the current study was to assess HRQOL in a group of patients with Dual Diagnosis compared to two other non-comorbid groups and to determine what clinical factors are related to HRQOL.

Methods

Cross-sectional assessment of three experimental groups was made through the Short Form – 36 Item Health Survey (SF-36). The sample consisted of a group with Dual Diagnosis (DD; N = 35), one with Severe Mental Illness alone (SMI; N = 35) and another one with Substance Use Dependence alone (SUD; N = 35). The sample was composed only by males. To assess the clinical correlates of SF-36 HRQOL, lineal regression analyses were carried out.

Results

The DD group showed lower scores in most of the subscales, and in the mental health domain. The group with SUD showed in general a better state in the HRQOL while the group with SMI held an intermediate position with respect to the other two groups. Daily medication, suicidal attempts and daily number of coffees were significantly associated to HRQOL, especially in the DD group.

Conclusions

The DD group showed lower self-reported mental health quality of life. Assessment of HRQOL in dual patients allows to identify specific needs in this population, and may help to establish therapeutic goals to improve interventions.
Appendix
Available only for authorised users
Literature
1.
go back to reference Zubaran C, Foresti K: Quality of life and substance use: concepts and recent tendencies. Curr Opin Psychiatr 2009, 22: 281–286. 10.1097/YCO.0b013e328328d154CrossRef Zubaran C, Foresti K: Quality of life and substance use: concepts and recent tendencies. Curr Opin Psychiatr 2009, 22: 281–286. 10.1097/YCO.0b013e328328d154CrossRef
2.
go back to reference Schaar I, Öjehagen A: Predictors of improvement in quality of life of severe mentally ill substance abusers during 18 months of co-operation between psychiatric and social services. Soc Psych Psych Epid 2009, 38: 83–87.CrossRef Schaar I, Öjehagen A: Predictors of improvement in quality of life of severe mentally ill substance abusers during 18 months of co-operation between psychiatric and social services. Soc Psych Psych Epid 2009, 38: 83–87.CrossRef
3.
go back to reference Meijer CJ, Koeter MWJ, Sprangers MAG, Schene AH: Predictors of general quality of life and the mediating role of health related quality of life in patients with schizophrenia. Soc Psych Psych Epid 2009, 44: 361–368. 10.1007/s00127-008-0448-4CrossRef Meijer CJ, Koeter MWJ, Sprangers MAG, Schene AH: Predictors of general quality of life and the mediating role of health related quality of life in patients with schizophrenia. Soc Psych Psych Epid 2009, 44: 361–368. 10.1007/s00127-008-0448-4CrossRef
4.
go back to reference Eack SM, Newhill CE: Psychiatric symptoms and quality of life in schizophrenia: a meta-analysis. Schizophrenia Bull 2007, 33: 1225–1237. 10.1093/schbul/sbl071CrossRef Eack SM, Newhill CE: Psychiatric symptoms and quality of life in schizophrenia: a meta-analysis. Schizophrenia Bull 2007, 33: 1225–1237. 10.1093/schbul/sbl071CrossRef
5.
go back to reference Brissos S, Videira-Dias V, Carita AI, Martínez A: Quality of life in bipolar type I disorder and schizophrenia in remission: clinical and neurocognitive correlates. Psychiat Res 2008, 160: 55–62. 10.1016/j.psychres.2007.04.010CrossRef Brissos S, Videira-Dias V, Carita AI, Martínez A: Quality of life in bipolar type I disorder and schizophrenia in remission: clinical and neurocognitive correlates. Psychiat Res 2008, 160: 55–62. 10.1016/j.psychres.2007.04.010CrossRef
6.
go back to reference Kao YC, Liu YP, Chou MK, Cheng TH: Subjective quality of life in patients with chronic schizophrenia: relationships between psychosocial and clinical characteristics. Compr Psychiat 2011, 52: 171–180. 10.1016/j.comppsych.2010.05.008CrossRefPubMed Kao YC, Liu YP, Chou MK, Cheng TH: Subjective quality of life in patients with chronic schizophrenia: relationships between psychosocial and clinical characteristics. Compr Psychiat 2011, 52: 171–180. 10.1016/j.comppsych.2010.05.008CrossRefPubMed
7.
go back to reference Samuli I, Saarni SI, Viertiö S, Perälä J, Koskinen S, Lönnqvist J: Quality of life of people with schizophrenia, bipolar disorder and other psychotic disorders. Brit J Psychiat. 2010, 197: 386–394. 10.1192/bjp.bp.109.076489CrossRef Samuli I, Saarni SI, Viertiö S, Perälä J, Koskinen S, Lönnqvist J: Quality of life of people with schizophrenia, bipolar disorder and other psychotic disorders. Brit J Psychiat. 2010, 197: 386–394. 10.1192/bjp.bp.109.076489CrossRef
8.
go back to reference Lozano OM, Domingo-Salvany A, Martínez-Alonso M, et al.: Health-related quality of life in young cocaine users and associated factors. Qual Life Res 2008, 17: 977–985. 10.1007/s11136-008-9376-8CrossRefPubMed Lozano OM, Domingo-Salvany A, Martínez-Alonso M, et al.: Health-related quality of life in young cocaine users and associated factors. Qual Life Res 2008, 17: 977–985. 10.1007/s11136-008-9376-8CrossRefPubMed
9.
go back to reference González-Saiz F, Lozano O, Iraurgi I: Measuring the impact of psychoactive substance on health-related quality of life: an update. Curr Drug Abuse Rev 2009, 2: 5–10. 10.2174/1874473710902010005CrossRefPubMed González-Saiz F, Lozano O, Iraurgi I: Measuring the impact of psychoactive substance on health-related quality of life: an update. Curr Drug Abuse Rev 2009, 2: 5–10. 10.2174/1874473710902010005CrossRefPubMed
10.
go back to reference Pyne JM, Tripathi S, French M, McCollister K, Rapp RC, Booth BM: Longitudinal association of preference-weighted health-related quality of life measures and substance use disorder outcomes. Addiction 2011, 106: 507–515. 10.1111/j.1360-0443.2010.03299.xPubMedCentralCrossRefPubMed Pyne JM, Tripathi S, French M, McCollister K, Rapp RC, Booth BM: Longitudinal association of preference-weighted health-related quality of life measures and substance use disorder outcomes. Addiction 2011, 106: 507–515. 10.1111/j.1360-0443.2010.03299.xPubMedCentralCrossRefPubMed
11.
go back to reference Bebout RR, Drake RE, Xie H, McHugo GJ, Harris M: Housing status among formerly homeless dually diagnosed adults. Psychiat Serv 1997, 48: 936–941.CrossRef Bebout RR, Drake RE, Xie H, McHugo GJ, Harris M: Housing status among formerly homeless dually diagnosed adults. Psychiat Serv 1997, 48: 936–941.CrossRef
12.
13.
go back to reference Rudolf H, Watts J: Quality of life in substance abuse and dependency. Int Rev Psychiatry 2002, 14: 190–197. 10.1080/09540260220144975CrossRef Rudolf H, Watts J: Quality of life in substance abuse and dependency. Int Rev Psychiatry 2002, 14: 190–197. 10.1080/09540260220144975CrossRef
14.
go back to reference Lamb HR, Lamb DM: Factors contributing to homelessness among the chronically and severely mental ill. Hosp Community Psychiatry 1990, 41: 301–305.PubMed Lamb HR, Lamb DM: Factors contributing to homelessness among the chronically and severely mental ill. Hosp Community Psychiatry 1990, 41: 301–305.PubMed
15.
go back to reference Singh J, Mattoo SK, Sharan P, Basu D: Quality of life and its correlates in patients with dual diagnosis of bipolar affective disorder and substance dependence. Bipolar Disord 2005, 7: 187–191. 10.1111/j.1399-5618.2004.00173.xCrossRefPubMed Singh J, Mattoo SK, Sharan P, Basu D: Quality of life and its correlates in patients with dual diagnosis of bipolar affective disorder and substance dependence. Bipolar Disord 2005, 7: 187–191. 10.1111/j.1399-5618.2004.00173.xCrossRefPubMed
16.
go back to reference Kilbourne AM, Perron BM, Mezuk B, Welsh D, Ilgen M, Bayer MS: Co-occurring conditions and health-related quality of life in patients with bipolar disorder. Psychosom Med 2009, 71: 894–900. 10.1097/PSY.0b013e3181b49948CrossRefPubMed Kilbourne AM, Perron BM, Mezuk B, Welsh D, Ilgen M, Bayer MS: Co-occurring conditions and health-related quality of life in patients with bipolar disorder. Psychosom Med 2009, 71: 894–900. 10.1097/PSY.0b013e3181b49948CrossRefPubMed
17.
go back to reference Kalman D, Lee A, Chan E, et al.: Alcohol dependence, other psychiatric disorders, and health related quality of life: a replication study in a large random sample of enrollees in the veterans health administration. Am J Drug Alcohol Abuse 2004, 30: 473–487. 10.1081/ADA-120037389CrossRefPubMed Kalman D, Lee A, Chan E, et al.: Alcohol dependence, other psychiatric disorders, and health related quality of life: a replication study in a large random sample of enrollees in the veterans health administration. Am J Drug Alcohol Abuse 2004, 30: 473–487. 10.1081/ADA-120037389CrossRefPubMed
18.
go back to reference Bizzarri J, Rucci P, Vallotta A, et al.: Dual diagnosis and quality of life in patients in treatment for opioid dependence. Subst Use Misuse 2005, 40: 1765–1776. 10.1080/10826080500260800CrossRefPubMed Bizzarri J, Rucci P, Vallotta A, et al.: Dual diagnosis and quality of life in patients in treatment for opioid dependence. Subst Use Misuse 2005, 40: 1765–1776. 10.1080/10826080500260800CrossRefPubMed
19.
go back to reference Fassino S, Abbate-Daga G, Delsedime N, Rogna L, Boggio S: Quality of life and personality disorders in heroin abusers. Drug Alcohol Depen 2004, 76: 73–80. 10.1016/j.drugalcdep.2004.04.005CrossRef Fassino S, Abbate-Daga G, Delsedime N, Rogna L, Boggio S: Quality of life and personality disorders in heroin abusers. Drug Alcohol Depen 2004, 76: 73–80. 10.1016/j.drugalcdep.2004.04.005CrossRef
20.
go back to reference Astals M, Domingo-Salvany A, Castillo-Buenaventura C, et al.: Impact of substance dependence and dual diagnosis on the quality of life of heroin users seeking treatment. Subst Use Misuse 2008, 43: 612–632. 10.1080/10826080701204813CrossRefPubMed Astals M, Domingo-Salvany A, Castillo-Buenaventura C, et al.: Impact of substance dependence and dual diagnosis on the quality of life of heroin users seeking treatment. Subst Use Misuse 2008, 43: 612–632. 10.1080/10826080701204813CrossRefPubMed
21.
go back to reference Garg N, Yates WR, Jones R, Zhou M, Williams S: Effects of gender, treatment site and psychiatric comorbidity on quality of life outcome in substance dependence. Am J Addict 1999, 8: 44–54. 10.1080/105504999306072CrossRefPubMed Garg N, Yates WR, Jones R, Zhou M, Williams S: Effects of gender, treatment site and psychiatric comorbidity on quality of life outcome in substance dependence. Am J Addict 1999, 8: 44–54. 10.1080/105504999306072CrossRefPubMed
22.
go back to reference Wade D, Harrigan S, McGorry PD, Burgess PM, Whealan G: Impact of severity of substance use disorder on symptomatic and functional outcome in young individuals with first-episode psychosis. J Clin Psychiat 2007, 68: 767–774. 10.4088/JCP.v68n0517CrossRef Wade D, Harrigan S, McGorry PD, Burgess PM, Whealan G: Impact of severity of substance use disorder on symptomatic and functional outcome in young individuals with first-episode psychosis. J Clin Psychiat 2007, 68: 767–774. 10.4088/JCP.v68n0517CrossRef
23.
go back to reference Alonso J, Regidor E, Barrio G, Prieto L, Rodríguez C, de la Fuente L: Valores poblacionales de referencia de la versión española del cuestionario de salud SF-36. Med Clin 1998, 111: 410–416. Alonso J, Regidor E, Barrio G, Prieto L, Rodríguez C, de la Fuente L: Valores poblacionales de referencia de la versión española del cuestionario de salud SF-36. Med Clin 1998, 111: 410–416.
24.
go back to reference American Psychiatric Association: Diagnostic and statistical manual of mental disorders. 4th edition. American Psychiatric Association, Washington, DC; 2002. American Psychiatric Association: Diagnostic and statistical manual of mental disorders. 4th edition. American Psychiatric Association, Washington, DC; 2002.
25.
go back to reference First MB: Entrevista Clínica Estructurada para los trastornos del eje I del DSM-IV-SCID-I. Masson, Barcelona; 1999. First MB: Entrevista Clínica Estructurada para los trastornos del eje I del DSM-IV-SCID-I. Masson, Barcelona; 1999.
26.
go back to reference Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO: The Fagerström test for nicotine dependence: a revision of the Fagerström tolerance questionnaire. Brit J Addiction 1991, 86: 1119–1127. 10.1111/j.1360-0443.1991.tb01879.xCrossRef Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO: The Fagerström test for nicotine dependence: a revision of the Fagerström tolerance questionnaire. Brit J Addiction 1991, 86: 1119–1127. 10.1111/j.1360-0443.1991.tb01879.xCrossRef
27.
go back to reference National Institute of Mental Health: CGI Clinical Global Impression. In Assessment manual for psychopharmacology. Edited by: Guy W, Bonato RR. Rockville; 1976:217–222. National Institute of Mental Health: CGI Clinical Global Impression. In Assessment manual for psychopharmacology. Edited by: Guy W, Bonato RR. Rockville; 1976:217–222.
28.
go back to reference Ware JE, Sherbourne CD: The MOS 36-item short-form health survey (SF-36). I. conceptual framework and item selection. Med Care 1992, 30: 473–483. 10.1097/00005650-199206000-00002CrossRefPubMed Ware JE, Sherbourne CD: The MOS 36-item short-form health survey (SF-36). I. conceptual framework and item selection. Med Care 1992, 30: 473–483. 10.1097/00005650-199206000-00002CrossRefPubMed
29.
go back to reference Leese M, Schene A, Koeter M, et al.: SF-36 scales, and simple sums scales, were reliable quality of life summaries for patients with schizophrenia. J Clin Epidemiol 2008, 61: 588–596. 10.1016/j.jclinepi.2007.08.004CrossRefPubMed Leese M, Schene A, Koeter M, et al.: SF-36 scales, and simple sums scales, were reliable quality of life summaries for patients with schizophrenia. J Clin Epidemiol 2008, 61: 588–596. 10.1016/j.jclinepi.2007.08.004CrossRefPubMed
30.
go back to reference Newnham EA, Harwood KE, Page AC: Evaluating the clinical significance of responses by psychiatric inpatients to the mental health subscales of the SF-36. J Affect Disorders 2007, 98: 91–97. 10.1016/j.jad.2006.07.001CrossRefPubMed Newnham EA, Harwood KE, Page AC: Evaluating the clinical significance of responses by psychiatric inpatients to the mental health subscales of the SF-36. J Affect Disorders 2007, 98: 91–97. 10.1016/j.jad.2006.07.001CrossRefPubMed
31.
go back to reference Morales-Manrique CC, Castellano-Gómez M, Valderrama-Zurián JC, Aleixandre-Benavent RA: Medición de la calidad de vida e importancia de la atención a las necesidades autopercibidas en pacientes drogodependientes. Trastornos Adictivos 2006, 8: 212–221. 10.1016/S1575-0973(06)75126-1CrossRef Morales-Manrique CC, Castellano-Gómez M, Valderrama-Zurián JC, Aleixandre-Benavent RA: Medición de la calidad de vida e importancia de la atención a las necesidades autopercibidas en pacientes drogodependientes. Trastornos Adictivos 2006, 8: 212–221. 10.1016/S1575-0973(06)75126-1CrossRef
32.
go back to reference Vilagut G, Valderas JM, Ferrer M, Garin O, López-García E, Alonso J: Interpretación de los cuestionarios de salud SF-36 y SF-12 en España: componentes físico y mental. Med Clin 2008, 130: 726–735. 10.1157/13121076CrossRef Vilagut G, Valderas JM, Ferrer M, Garin O, López-García E, Alonso J: Interpretación de los cuestionarios de salud SF-36 y SF-12 en España: componentes físico y mental. Med Clin 2008, 130: 726–735. 10.1157/13121076CrossRef
33.
go back to reference Huberty CJ: A history of effect sizes indices. Educ Psychol Meas 2002, 62: 227–240. 10.1177/0013164402062002002CrossRef Huberty CJ: A history of effect sizes indices. Educ Psychol Meas 2002, 62: 227–240. 10.1177/0013164402062002002CrossRef
34.
go back to reference Bebbington PE, Angermeyer M, Azorin JM, Marwaha S, Marteau F, Tourni M: Side-effects of antipsychotic medication and health-related quality of life in schizophrenia. Acta Psychiat Scand 2009, 119: 22–28.CrossRef Bebbington PE, Angermeyer M, Azorin JM, Marwaha S, Marteau F, Tourni M: Side-effects of antipsychotic medication and health-related quality of life in schizophrenia. Acta Psychiat Scand 2009, 119: 22–28.CrossRef
35.
go back to reference Laaksnonen M, Rahkonen O, Martikainen P, Karvonen S, Lahelma E: Smoking and SF-36 health functioning. Prev Med 2006, 42: 206–209. 10.1016/j.ypmed.2005.12.003CrossRef Laaksnonen M, Rahkonen O, Martikainen P, Karvonen S, Lahelma E: Smoking and SF-36 health functioning. Prev Med 2006, 42: 206–209. 10.1016/j.ypmed.2005.12.003CrossRef
36.
go back to reference Ponizovsky AM, Grinshpoon A, Levav I, Ritsner MS: Life satisfaction and suicidal attempts among persons with schizophrenia. Compr Psychiat 2003, 44: 442–447. 10.1016/S0010-440X(03)00146-9CrossRefPubMed Ponizovsky AM, Grinshpoon A, Levav I, Ritsner MS: Life satisfaction and suicidal attempts among persons with schizophrenia. Compr Psychiat 2003, 44: 442–447. 10.1016/S0010-440X(03)00146-9CrossRefPubMed
37.
go back to reference Casas M, Torrens M, Duro P, Pinet C, Alvarez E, Udina C: Utilisation des méthylxanthines, caffeine et théophylline dans le traitement des troubles extrapyramidaux secondaires aux traitements par les neuroleptiques. Déroulement d’une hyphotèse thérapeutique. L’encephale 1989, 15: 177–180.PubMed Casas M, Torrens M, Duro P, Pinet C, Alvarez E, Udina C: Utilisation des méthylxanthines, caffeine et théophylline dans le traitement des troubles extrapyramidaux secondaires aux traitements par les neuroleptiques. Déroulement d’une hyphotèse thérapeutique. L’encephale 1989, 15: 177–180.PubMed
38.
go back to reference Paton C, Beer D: Caffeine: the forgotten variable. Int J Psychiat Clin 2001, 5: 231–236. 10.1080/13651500152732991CrossRef Paton C, Beer D: Caffeine: the forgotten variable. Int J Psychiat Clin 2001, 5: 231–236. 10.1080/13651500152732991CrossRef
39.
go back to reference Lara D: Caffeine, mental health, and psychiatric disorders. J Alz Dis 2010, 20: 239–248. Lara D: Caffeine, mental health, and psychiatric disorders. J Alz Dis 2010, 20: 239–248.
40.
go back to reference Baethge C, Tondo L, Lepri B, Baldessarini RJ: Coffee and cigarette use: association with suicidal acts in 352 Sardinian bipolar disorder patients. Bipolar Disord 2009, 11: 494–503. 10.1111/j.1399-5618.2009.00727.xCrossRefPubMed Baethge C, Tondo L, Lepri B, Baldessarini RJ: Coffee and cigarette use: association with suicidal acts in 352 Sardinian bipolar disorder patients. Bipolar Disord 2009, 11: 494–503. 10.1111/j.1399-5618.2009.00727.xCrossRefPubMed
41.
go back to reference Keizer I, Gex-Fabry M, Eytan A, Bertschy G: Smoking in psychiatric inpatients: association with working status, diagnosis, comorbid substance use and history of suicide attempts. Addict Behav 2009, 34: 815–820. 10.1016/j.addbeh.2009.03.018CrossRefPubMed Keizer I, Gex-Fabry M, Eytan A, Bertschy G: Smoking in psychiatric inpatients: association with working status, diagnosis, comorbid substance use and history of suicide attempts. Addict Behav 2009, 34: 815–820. 10.1016/j.addbeh.2009.03.018CrossRefPubMed
42.
go back to reference Alonso J, Croudace T, Brown J, et al.: Health-related quality of life (HRQL) and continuous antipsychotic treatment: 3-year results from the Schizophrenia Health Outcomes (SOHO) Study. Value Health 2009, 12: 536–543. 10.1111/j.1524-4733.2008.00495.xCrossRefPubMed Alonso J, Croudace T, Brown J, et al.: Health-related quality of life (HRQL) and continuous antipsychotic treatment: 3-year results from the Schizophrenia Health Outcomes (SOHO) Study. Value Health 2009, 12: 536–543. 10.1111/j.1524-4733.2008.00495.xCrossRefPubMed
43.
go back to reference Kasckow J, Montross L, Golshan S, et al.: Suicidality in middle aged and older patients with schizophrenia and depressive symptoms: Relationship to functioning and quality of life. Int J Geriatr Psych 2007, 22: 1223–1228. 10.1002/gps.1817CrossRef Kasckow J, Montross L, Golshan S, et al.: Suicidality in middle aged and older patients with schizophrenia and depressive symptoms: Relationship to functioning and quality of life. Int J Geriatr Psych 2007, 22: 1223–1228. 10.1002/gps.1817CrossRef
44.
go back to reference Lev-Ran S, Imtiaz S, Taylor BJ, Shield KD, Rehm J, Le Foll B: Gender difference in health-related quality of life among cannabis users: results from the national epidemiologic survey on alcohol related condictions. Drug Alcohol Depen 2012, 123: 190–200. 10.1016/j.drugalcdep.2011.11.010CrossRef Lev-Ran S, Imtiaz S, Taylor BJ, Shield KD, Rehm J, Le Foll B: Gender difference in health-related quality of life among cannabis users: results from the national epidemiologic survey on alcohol related condictions. Drug Alcohol Depen 2012, 123: 190–200. 10.1016/j.drugalcdep.2011.11.010CrossRef
Metadata
Title
Health-related quality of life in patients with dual diagnosis: clinical correlates
Authors
Irina Benaiges
Gemma Prat
Ana Adan
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Health and Quality of Life Outcomes / Issue 1/2012
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/1477-7525-10-106

Other articles of this Issue 1/2012

Health and Quality of Life Outcomes 1/2012 Go to the issue